A Human CD137×PD-L1 Bispecific Antibody Promotes Anti-tumor Immunity via Context-Dependent T Cell Costimulation and Checkpoint Blockade

0
53
Researchers described a human CD137xPD-L1 bispecific antibody, MCLA-145, identified through functional screening of agonist- and immune checkpoint inhibitor arm combinations.
[Nature Communications]
Full Article